FDA Approves New Hepatitis C Drug | BlackDoctor

    FDA Approves New Hepatitis C Drug

    (BlackDoctor.org) — The FDA today approved a new drug called Victrelis (boceprevir) to treat certain adults with chronic hepatitis C.

    “Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment,” an FDA news release states.

    The FDA approved Victrelis for use with standard hepatitis C treatments. An FDA advisory panel recently voted to recommend the drug’s approval.

    The agency’s approval of Victrelis is based on two studies that included 1,500 adults with hepatitis C. In those studies, in two-thirds of patients receiving Victrelis — in combination with two standard hepatitis C drugs — the hepatitis C virus was undetectable in their blood 24 weeks after treatment stopped.

    1 2Next page »


    Get every new post delivered to your Inbox.

    Join 2,656 other followers